08. December 2024 - Reading time: 2 min.
The MEDICA Fair, held annually in Düsseldorf, Germany, is one of the world’s largest medical events, showcasing a wide range of innovative products and services in medical technology, laboratory equipment, digital health solutions, and diagnostic methods. In 2024, it took place from November 11 to 14 in Düsseldorf.
Just 1.5 months after the official market release of our solution, OncoPrevia — the software for personalized cancer early detection — we participated as exhibitors at hashtag MEDICA with Oncosia Scientific GmbH at the joint stand of Bayern Innovativ GmbH.
At MEDICA, which brought together over 5,300 participating companies and more than 83,000 visitors from 70+ countries, impressive innovations in diagnostics and prevention were showcased.
This is where we step in with our OncoPrevia solution. It offers accessible, systematic, and low-threshold risk identification for various cancers — the first step in reaching those who can benefit the most from targeted measures.
And here are the outcomes we achieved and some key takeaways from MEDICA 2024!
At MEDICA, we had the chance to gather valuable live feedback from potential users and partners. The discussions were full of technical, honest critique, and positive feedback.
They showed us that we are on the right track, but the market also brings new and exciting requirements. We are already taking steps to address these demands.
Our stand might have been small, but the interest was overwhelming: From morning to evening, we had fascinating conversations with numerous visitors.
The topic of “Personalized Cancer Early Detection” clearly resonates with the times. This strong turnout delighted and motivated us.
MEDICA provided an excellent platform to brainstorm with like-minded individuals about the future of personalized medicine.
We look forward to the coming months, as these discussions have paved the way for exciting approaches.
Beyond professional achievements, MEDICA was also a fantastic team event. Together, we refined our vision, gathered new ideas, and grew stronger as a team. And most importantly, we had a great time.
Many thanks to my dear colleagues Berfin Sezen Cantepe and Seval Beykan.
Just weeks after the market launch, MEDICA was the ideal stage for us to present our solution, OncoPrevia, gather feedback, and build new partnerships.
The feedback confirmed that personalized cancer early detection is the right path — and we are ready to continue on it.
For more information, visit our dedicated Webpage about OncoPrevia
Oncosia Scientific was founded in 2024 with the mission of integrating personalized medicine into healthcare – with a special focus on the prevention, early detection, diagnosis, and treatment of cancer. Our innovative solutions are designed for both patients and doctors, based on scientific knowledge to ensure individualized and optimal care.
Oncosia Scientific GmbH
mail@oncosia.de
+49 (0) 160 96255919
© 2025 Oncosia Scientific GmbH. All rights reserved